All

Enterome Receives FDA IND Clearance for EO2463, an ‘OncoMimic’ based Immunotherapy Targeting Liquid Tumors
24 March 2021

Enterome Receives FDA IND Clearance for EO2463, an ‘OncoMimic’ based Immunotherapy Targeting Liquid Tumors

Phase1/2 clinical trials in patients with follicular lymphoma and marginal zone lymphoma expected to begin in Q2 2021

ENTEROME SA, a clinical stage biopharmaceutical...

Read the press release
Isabelle de Cremoux, CEO and Managing Partner, Seventure Partners explains Why investors need to think beyond ESG
18 March 2021

Isabelle de Cremoux, CEO and Managing Partner, Seventure Partners explains Why investors need to think beyond ESG

Calls for genuine corporate responsibility efforts have been high on the agenda for some time, but the pandemic — and its wide-ranging impact on all organisations, including...

Read more
MaaT Pharma Announces Positive Topline Results from Phase 2 HERACLES Clinical Trial with Lead Microbiome Ecosystem Therapy MaaT013 in Patients with Acute Graft-versus-Host Disease
17 March 2021

MaaT Pharma Announces Positive Topline Results from Phase 2 HERACLES Clinical Trial with Lead Microbiome Ecosystem Therapy MaaT013 in Patients with Acute Graft-versus-Host Disease

MaaT Pharma announced today positive topline results from its Phase 2 clinical trial evaluating lead microbiome ecosystem therapy, MaaT013, in a high-risk patient population...

Read the press release
YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders,  as well as the Inclusion of the Obese Patients in the Second Arm of the Trial
4 March 2021

YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders, as well as the Inclusion of the Obese Patients in the Second Arm of the Trial

YSOPIA Bioscience, a French clinical stage biotechnology company specializing in the research and development of innovative drugs using the properties of key bacterial strains...

Read the press release
3 March 2021

IDnow Acquires identity Trust Management AG, a Leading Identity Verification Provider in Germany

IDnow, a leading provider of Identity Verification-as-a-Service solutions, today announced that it has agreed to acquire identity Trust Management AG, a leading international...

Read more
BiomX Announces Dosing of First Subject in Phase 2 Study of BX001 for Acne-Prone Skin
2 March 2021

BiomX Announces Dosing of First Subject in Phase 2 Study of BX001 for Acne-Prone Skin

BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing both natural and engineered phage therapies that target specific pathogenic bacteria, today announced that...

Read the press release
Isabelle de Cremoux, CEO and Managing Partner, Seventure Partners explains Why microbiota samples should be collected in all clinical trials?
26 January 2021

Isabelle de Cremoux, CEO and Managing Partner, Seventure Partners explains Why microbiota samples should be collected in all clinical trials?

In recent years, the understanding of how the microbiome and human health are linked has expanded considerably. We believe the rise in this understanding and the growing...

Read more
‘Significant interest’: Venture capital major Seventure Partners extends €200m+ microbiome fund
13 January 2021

‘Significant interest’: Venture capital major Seventure Partners extends €200m+ microbiome fund

European life sciences investment firm Seventure Partners has extended the final close of its second microbiome innovation fund and increased focus on advances in the skin...

Read more
Health for Life Capital II™ fund, managed by Seventure Partners, makes two new immuno-oncology (I/O) investments
9 February 2021

Health for Life Capital II™ fund, managed by Seventure Partners, makes two new immuno-oncology (I/O) investments

Seventure led $10M round for new French company focusing on I/O-microbiome and provided $3M seed funding to ErVaccine, driving an increased I/O microbiome focus in fund...

Read the press release
2 February 2021

SumUp acquires Lithuanian mobile banking platform Paysolut

Global payments player SumUp has acquired the Lithuanian-born core banking system provider Paysolut, according to a press release shared exclusively with Tech.eu.

Read more

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse